| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
55,949 |
54,652 |
$2.79M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,107 |
5,969 |
$426K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,831 |
7,680 |
$233K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,731 |
16,369 |
$227K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
785 |
776 |
$53K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,790 |
1,960 |
$33K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
437 |
434 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
816 |
780 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,680 |
1,628 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
630 |
605 |
$6K |
| 81003 |
|
2,226 |
2,186 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
156 |
152 |
$3K |
| 99201 |
|
79 |
79 |
$3K |
| 81025 |
|
352 |
347 |
$3K |
| 81002 |
|
650 |
639 |
$1K |
| 87807 |
|
90 |
88 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
201 |
196 |
$416.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
297 |
297 |
$227.65 |
| 86308 |
|
45 |
41 |
$217.33 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
30 |
28 |
$180.76 |
| 82962 |
|
67 |
67 |
$167.30 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
60 |
57 |
$85.28 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
266 |
264 |
$50.08 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
55 |
55 |
$9.61 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
56 |
54 |
$6.25 |
| J7510 |
Prednisolone oral, per 5 mg |
13 |
13 |
$4.76 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$0.60 |